Search

Protecting the Rights of Corporate Clients Companies generally enjoy a fruitful relationship with their shareholders, but disagreements about management, perceptions of minority shareholder mistreatment, or concerns over executive compensation may arise. No matter the cause of shareholder...

The pharmaceutical industry faces a challenging business environment as competition drives down prices, R&D expenses rise, and government scrutiny deepens. However, companies have many options for navigating these challenges, generally by making deals with others in the field, including mergers and...

Tom Murray is a patent agent who helps clients protect their intellectual property through patent preparation and prosecution, as well as analyses involving freedom to operate, non-infringement and invalidity. Tom also has experience with matters involving post-grant prosecutions. His IP work for...

Michelle Streifthau-Livizos represents clients in litigation matters, including disputes involving the Hatch-Waxman Act, patents, copyrights and trademarks. She handles cases involving various types of technology, including representations of pharmaceutical companies, life sciences companies...

Lukas Pfannenstiel draws on his scientific background to assist clients in protecting their intellectual property. Lukas has a Ph.D. in cellular and molecular medicine from Johns Hopkins University School of Medicine, a bachelor's degree in cell biology from University of Kansas, and practical...

Joel's practice often places him in the role of "outside general counsel" to clients, working closely with and advising company executives, boards, and members to successfully close transactional matters and manage corporate governance matters. Joel's experience includes negotiating, drafting and...

Brenda Glaser Abrams provides legal counsel on business contracts for health care industry clients, as well as on their operational and compliance issues. Physicians, dentists, and medical groups rely on her to negotiate and draft employment, shareholder, operating, and partnerships agreements. She...

Saul Ewing securities attorneys Justin B. Ettelson, Michael A. Gold, Mark I. Gruhin, Andrew F. Barris and Jourdan S. Garvey have co-edited the 2021 edition of SEC Reporting Rules books.* For those responsible for filing reports with the SEC for public companies, the 2021 SEC Reporting Rules books...

Yogini Bhavsar-Jog (Ph.D.) focuses on drafting and prosecuting patents in the areas including biochemistry, molecular biology, pharmaceuticals, biologics, nanotechnology, physics, chemical engineering and medical devices. In addition to the United States, Yogini is involved in managing prosecution...

Valerie O'Shea Murray, Ph.D., is a registered patent agent who prepares and prosecutes patent applications in a broad spectrum of technology areas, including biotechnology, immunology, chemistry, and life sciences. Valerie's intellectual property experience includes work for a variety of clients...

Bruce Armon counsels clients on how federal and state health care laws affect health care businesses. His understanding of corporate health care stems from a combination of his work with physicians, physician groups, hospitals, academic medical centers, ancillary providers, device manufacturers...

An Experienced Legal Team for the Entire Life Cycle of a Fund The complexities of forming and managing an investment fund are vast and varied — from changing market trends and investment strategies, to shifting tax and regulatory requirements. Navigating this landscape while maximizing return on...

Sarah Sullivan represents pharmaceutical companies involved in complex, high stakes patent litigation. Sarah concentrates her practice on Hatch-Waxman ANDA cases and disputes over the intellectual property behind branded pharmaceuticals. She is part of the Firm's nationally-recognized team for...

Saul Ewing attorneys understand the risks companies and individuals face when their intellectual property and brand are threatened, and we have deep experience helping clients protect their IP rights when disputes escalate to litigation. Our attorneys handle a variety of IP litigation cases across a...

Scott Patterson centers his practice on negotiating contracts for procurement and licensing of complex technology. He has helped numerous clients to structure effective RFPs and negotiate agreements for a wide range of enterprise information systems, cloud/SaaS services, telecommunications systems...

Max Bremer advises entrepreneurs and established companies on key transactions throughout the business life cycle, from formations and financings to mergers, acquisitions and divestitures. Max works with clients in a variety of industries, including health care IT, medical devices, data analytics...

Saul Ewing’s Litigation Department features approximately 200 attorneys across 18 offices. We handle a wide range of matters including complex business and commercial disputes, bet-the-company legal proceedings, and high-profile cases in state and federal courts and Alternative Dispute Resolution...

Saul Ewing’s Shareholder Litigation Practice is national, but we have substantial strength in Maryland. It is the second most popular state of incorporation for companies listed on the New York Stock Exchange and the state in which more than 80 percent of all publicly registered REITs are formed...

Saul Ewing’s experienced patent attorneys assist companies and institutions in securing, leveraging, and enforcing commercially valuable intellectual property. From developing patent strategies on a global scale to vigorously asserting and defending patents in court, our team serves as trusted...

Charlie Lizza brings more than 40 years of litigation experience to his representation of pharmaceutical companies in high stakes patent litigation. Mr. Lizza concentrates his practice in Hatch-Waxman ANDA litigation and protecting the intellectual property of branded pharmaceutical and medical...